Prediction of Alzheimer's dementia risk based on interpretable machine learning
返回论文页
|更新时间:2024-05-09
|
Prediction of Alzheimer's dementia risk based on interpretable machine learning
New Generation of Information TechnologyPages: 1-5(2024)
作者机构:
1.牡丹江医学院医学影像学院,黑龙江 牡丹江,157011
2.牡丹江医学院附属红旗医院,黑龙江 牡丹江,157011
作者简介:
基金信息:
DOI:
CLC:R195
Published Online:09 May 2024,
扫 描 看 全 文
富丹,孙悦,郭金兴等.基于可解释性机器学习的阿尔兹海默症痴呆风险预测[J].新一代信息技术,
Fu Dan,Sun Yue,Guo Jinxin,et al.Prediction of Alzheimer's dementia risk based on interpretable machine learning[J].New Generation of Information Technology,
Fu Dan,Sun Yue,Guo Jinxin,et al.Prediction of Alzheimer's dementia risk based on interpretable machine learning[J].New Generation of Information Technology,DOI:10.3969/j.issn.2096-6091.XXXX.XX.001.
Prediction of Alzheimer's dementia risk based on interpretable machine learning
Alzheimer's disease (AD) is one of the important challenges facing society today
however
early diagnosis is essential for effective treatment. This study explores the application of machine learning algorithms in predicting AD risk and uses a variety of models for comparison. The results show that although the model selection is rich
the prediction effect is not ideal due to missing values in the data set. SHAP profile analysis revealed the key role of depression and APOE ε4 allele in model prediction. Future studies should further explore the influence of these genetic and environmental factors on the pathogenesis of AD
and optimize predictive models with advanced technologies to improve early diagnosis and intervention capabilities
and provide more accurate and effective methods for the prevention and treatment of Alzheimer's disease.
BUSH A I. The metallobiology of Alzheimer's disease[J]. Trends in neurosciences, 2003, 26(4): 207-214.
DETURE M A, DICKSON D W. The neuropathological diagnosis of Alzheimer's disease[J]. Molecular neurodegeneration, 2019, 14(1): 32.
SCHELTENS P, DE STROOPER B, KIVIPELTO M, et al. Alzheimer's disease[J]. The Lancet, 2021, 397(10284): 1577-1590.
Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, et al. Alzheimer's disease: an updated overview of its genetics[J]. International journal of molecular sciences, 2023, 24(4): 3754.
SALEH H, ELRASHIDY N, ABD ELAZIZ M, et al. Genetic algorithm-based hybrid deep learning model for explainable Alzheimer's disease prediction using temporal multimodal cognitive data[J]. International Journal of Data Science and Analytics, 2024: 1-31.
TU Y, LIN S, QIAO J, et al. Multimodal fusion diagnosis of Alzheimer's disease based on FDG-PET generation[J]. Biomedical Signal Processing and Control, 2024, 89: 105709.
YAMAZAKI Y, ZHAO N, CAULFIELD T R, et al. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies[J]. Nature Reviews Neurology, 2019, 15(9): 501-518.
CORBO R M, SCACCHI R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE* 4 a 'thrifty'allele?[J]. Annals of human genetics, 1999, 63(4): 301-310.
BOYLE P A, BUCHMAN A S, WILSON R S, et al. The APOE ε 4 allele is associated with incident mild cognitive impairment among community-dwelling older persons[J]. Neuroepidemiology, 2010, 34(1): 43-49.
ENGELBORGHS S, SLEEGERS K, CRAS P, et al. No association of CSF biomarkers with APOE ε 4, plaque and tangle burden in definite Alzheimer's disease[J]. Brain, 2007, 130(9): 2320-2326.
BERGER T, LEE H, YOUNG A H, et al. Adult hippocampal neurogenesis in major depressive disorder and Alzheimer's disease[J]. Trends in molecular medicine, 2020, 26(9): 803-818.